ImmunityBio (IBRX) Gross Margin (2023 - 2026)
ImmunityBio (IBRX) posted quarterly Gross Margin of 99.46% for Q1 2026, down 19.0% year-over-year from 122.79% in Q1 2025, and little changed quarter-over-quarter from 99.0% in Q4 2025.
ImmunityBio (IBRX) Gross Margin (2023 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Gross Margin for 4 consecutive years, with 99.46% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 19.0% year-over-year to 99.46%; the TTM figure through Mar 2026 stood at 99.34% (down 48.0% YoY), while the FY2025 annual figure was 99.34%, down 66.0% from the prior year.
- Gross Margin was little changed at 99.46% in Q1 2026 per IBRX's latest filing, from 99.0% in the prior quarter.
- Across five years, Gross Margin topped out at 100.0% in Q2 2023 and bottomed at 99.0% in Q4 2025.
- Historically, Gross Margin has averaged 99.75% across 4 years, with a median of 100.0% in 2023.
- Annual changes were most pronounced in 2024 — Gross Margin changed 0 bps — and 2025, when it tumbled 100 bps.
- ImmunityBio's Gross Margin stood at 100.0% in 2023, then changed by 0 bps to 100.0% in 2024, then decreased by 1 bps to 99.0% in 2025, then gained by 0 bps to 99.46% in 2026.
- Business Quant data shows IBRX's Gross Margin at 99.46% in Q1 2026, 99.0% in Q4 2025, and 99.45% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn | 99.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.42% |
| Mar 31, 2026 | 99.46% |
| Dec 31, 2025 | 99.00% |
| Sep 30, 2025 | 99.45% |
| Jun 30, 2025 | 99.49% |
| Mar 31, 2025 | 99.65% |
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 100.00% |